eCBS	Endocannabinoid system
eCBs	Endocannabinoids
GPCR	G-protein-coupled receptors
CB1 and CB2, respectively	Cannabinoid receptors type 1 and 2
anandamide, AEA	N-arachidonoylethanolamide
2-AG	2-arachidonoylglycerol
ICIs	Immune Checkpoint Inhibitors
CTLA4	Cytotoxic T-lymphocyte-associated protein 4
PD-1	Programmed cell death protein 1
PD-L1	Programmed Death-ligand 1
NSCLC	Non-Small Cell Lung Cancer
I-G	Immunotherapy Group
IC-G	Immunotherapy-Cannabis Group
CR	Complete response
PR	Partial response
SD	Stable disease
DEA	Drug Enforcement Administration
TTP	Time to tumor progression
OS	Overall Survival
AEs	Adverse events
CTLs	Cytotoxic T Lymphocytes